z-logo
open-access-imgOpen Access
A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909)
Author(s) -
Zheng Yan,
Xianben Liu,
Haibo Sun,
Jinliang Xu,
Sining Shen,
Yufeng Ba,
Ming Yan,
Zimin Qin,
Baoxing Liu,
Zongfei Wang,
Shilei Liu,
Ruixiang Zhang,
Peinan Chen,
Guanghui Liang,
Dongfeng Yuan,
Zhen-xuan Li,
Qi Liu,
Haoran Wang,
Haomiao Li,
Hongwei Lv,
Xiaochao Ma,
Jianping Zhu,
Yongkui Yu,
Wenqun Xing
Publication year - 2021
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-20-5404
Subject(s) - medicine , oncology , clinical endpoint , esophageal cancer , chemotherapy , neoadjuvant therapy , cancer , chemoradiotherapy , adverse effect , phases of clinical research , clinical trial , breast cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom